October 4th 2025
In the conclusion of this three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.
Understanding the Potential of Artificial Intelligence Across the Pharmaceutical Lifecycle
August 10th 2017Artificial intelligence offers a number of opportunities in pharmaceutical drug development and manufacturing, but there are barriers to overcome, notably around how well and how quickly the regulatory environment can adapt and keep pace with to the rapid changes.
How to Avoid the Number One Reason for Receiving FDA 483s
March 15th 2017An enterprise quality management software system can minimize human error and help pharmaceutical manufacturers maintain standard operating procedures to prevent deviations from GMP resulting from not having or following written procedures.